Expression of human nerve growth factor β gene in central nervous system mediated by recombinant adeno-associated viruses type-2 vector

Chinese Medical Journal

Volumn 117, Issue 9, 2004, Pages 1370-1376

  Gao, Kai ^a   Wu, Yong Jie ^b   Wu, Xiao Bing ^c   Rao, Chun Ming ^a   Wang, Jun Zhi ^a  

^a Biological Products   (China)

^b Lanzhou Jiaotong Universtiy   (China)

^c AGTC Gene Technology Company Ltd   (China)

Author keywords

Adeno associated virus; Blood brain barrier; Gene therapy; Human nerve growth factor

Indexed keywords

GREEN FLUORESCENT PROTEIN; MANNITOL; NERVE GROWTH FACTOR BETA SUBUNIT; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD BRAIN BARRIER; BRAIN TISSUE; CELL STRAIN BHK; CENTRAL NERVOUS SYSTEM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; INTERNAL CAROTID ARTERY; INTUBATION; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; STATISTICAL ANALYSIS; SUPERNATANT; TISSUE SECTION; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CRICETINAE; DEPENDOVIRUS; GENETIC VECTORS; HUMANS; NERVE GROWTH FACTOR; RECOMBINATION, GENETIC;

EID: 4844231305     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986;6:2155-2162.
2. Tuszynski MH, Roberts J, Senut MC, et al. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 1996;3:305-314.
3. Smith DE, Roberts J, Gage FH, et al. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci U S A 1999;96:10893-10898.
4. Martinez-Serrano A, Fischer W, Soderstrom S, et al. Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain. Proc Natl Acad Sci U S A 1996;93:6355-6360.
5. Martinez-Serrano A, Bjorklund A. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc Natl Acad Sci U S A 1998;95:1858-1863.
6. Mandel RJ, Spratt SK, Snyder RO, et al. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurones in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A 1997; 94:14083-14088.
7. Klein RL, Hirko AC, Meyers CA, et al. NGF gene transfer to intrinsic basal forebrain neurones increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats. Brain Res 2000;875:144-151.
8. Wang N, Zeng M, Ruan Y, et al. Protection of retinal ganglion cells against glaucomatous neuropathy by neurotrophin-producing, genetically modified neural progenitor cells in a rat model. Chin Med J 2002;115:1394-1400.
9. Humpel C, Weis C. Nerve growth factor and cholinergic CNS neurones studied in organotypic brain slices. Implication in Alzheimer's disease? J Neural Transm Suppl 2002;(62):253-263.
10. Cadete-Leite A, Pereira PA, Madeira MD, et al. Nerve growth factor prevents cell death and induces hypertrophy of basal forebrain cholinergic neurones in rats withdrawn from prolonged ethanol intake. Neuroscience 2003;119:1055-1069.
11. Tuszynski MH, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res 2004;146:441-449.
12. Neuwelt EA, Barnett PA, Hellstrom I, et al. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragtragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res 1988;48:4725-4729.
13. Sanovich E, Bartus RT, Friden PM, et al. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res 1995;705:125-135.
14. Spellerberg B, Prasad S, Cabellos C, et al. Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bactieral glycopeptides. J Exp Med 1995;182:1037-1043.
15. Tuomamen EI, Prasad SM, George JS, et al. Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A 1993;90:7824-7828.
16. Pardridge WM. Neurotrophins, neuroprotection and the blood-brain barrier. Curr Opin Investig Drugs 2002;3:1753-1757.
17. Neuwelt EA, Weissleder R, Nilaver G, et al. Delivery of virus-sized iron oxide particles to rodent CNS neurones. Neurosurgery 1994;34:777-784.
18. Wu ZJ, Wu XB, Hou YD. Construction of a series of adeno-associated virus vectors and their expression of β -galactosidase gene. Chin J Virol (Chin) 2000;16:1-6.
19. Wu XB, Dong XY, Wu ZJ, et al. A novel technique for adeno-associated virus purification. Chin Sci Bull 2000;45:2071-2075.
20. Debelak D, Fisher J, Iuliano S, et al. Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus type 2. J Chromatogr B 2000;740:195-202.
21. Wang JZ, eds. Research, development and quality control of bio-pharmaceutics. Beijing: Science Press; 2002:476-478.
22. Doran SE, Ren XD, Betz AL, et al. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 1995;36:965-970.
23. Muldoon LL, Nilaver G, Kroll RA, et al. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus and iron oxide particles to normal rat brain. Am J Pathol 1995;147:1840-1851.
24. Song S, Morgan M, Ellis T, et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A 1998;95:14384-14388.
25. Nguyen JT, Wu P, Clouse ME, et al. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res 1998;58:5673-5677.
26. Liu DW, Tsao YP, Kung JT, et al. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000;74:2888-2894.
27. High KA. AAV-mediated gene transfer for hemophilia. Trans Am Clin Climatol Assoc 2003;114:337-351.
28. Haworth R, Pilling AM. The PCR assay in the preclinical safety evaluation of nucleic acid medicines. Hum Exp Toxicol 2000;19:267-276.
29. Arruda VR, Fields PA, Milner R, et al. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol Ther 2001;4:586-592.